VistaGen Therapeutics (NASDAQ: VTGN) today announced the appointment of pharmaceutical industry veteran, Ann Cunningham, to the Company’s Board of Directors ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE